procedur
patient
develop
fever
lethargi
neck
stiff
analysi
ventricular
csf
reveal
white
cellsmm
white
cell
neutrophil
glucos
level
mgdl
glucos
level
blood
mgdl
protein
mgdl
microscop
examin
gram
stain
show
yeast
microorgan
cultur
posit
c
albican
three
separ
sampl
blood
cultur
steril
patient
treat
fluconazol
mg
intraven
iv
daili
oxacillin
g
iv
daili
rifampicin
mg
iv
daili
mening
persist
twenti
day
stroke
patient
admit
infecti
diseas
unit
extern
shunt
remov
replac
immedi
therapi
ambisom
mgkgday
flucytosin
mgkgday
start
addit
day
new
treatment
intraventricular
amphotericin
b
deoxychol
inject
shunt
dose
mg
daili
shunt
close
h
despit
therapi
patient
torpid
clinic
cours
fluid
clinic
condit
improv
without
complet
resolut
csf
cultur
posit
day
therapi
neg
follow
day
drug
regimen
serial
csf
serum
sampl
taken
check
amphotericin
b
level
sampl
also
taken
intraventricular
infus
sampl
store
assay
day
patient
die
result
second
haemorrhag
stroke
amphotericin
b
concentr
patient
csf
serum
sampl
analys
hplc
describ
bekerski
et
al
perform
standard
curv
amphotericin
b
regress
analysi
peak
serum
level
amphotericin
b
mgl
area
concentrationtim
curv
auc
amphotericin
b
concentr
ventricular
csf
mgl
auc
concentr
ventricular
amphotericin
b
taken
intrathec
administr
rang
h
intrashunt
infus
mgl
concentr
amphotericin
b
lumbar
fluid
mgl
fluid
sampl
obtain
singl
lumbar
punctur
h
intrashunt
infus
amphotericin
b
h
ambisom
iv
one
major
concern
therapi
fungal
shunt
infect
csf
penetr
system
administ
amphotericin
b
current
c
albican
consid
suscept
amphotericin
b
concentr
mgl
mic
mgl
minim
drug
concentr
achiev
infect
site
least
equal
mic
infect
organ
vivo
ratio
maximum
concentr
drug
c
max
mic
valu
best
predictor
outcom
convent
amphotericin
b
deoxychol
notori
inabl
achiev
consist
measur
concentr
csf
rang
undetect
serum
concentr
potenti
strategi
reduc
toxic
increas
therapeut
index
amphotericin
b
use
lipid
formul
drug
allow
administr
much
higher
dose
case
administr
ambisom
mgkgday
result
significantli
enhanc
amphotericin
b
concentr
csf
fact
fluid
c
max
submic
concentr
limit
clinic
result
obtain
data
show
poor
penetr
csf
liposom
amphotericin
b
dose
mgkgday
csf
auc
equival
serum
auc
intrathec
amphotericin
b
therapi
administ
day
case
achiev
temporari
elev
concentr
ventricular
csf
contribut
clinic
outcom
cn
penetr
base
c
max
increas
intraven
liposom
amphotericin
dosag
advoc
treat
cn
candida
infect
clinic
situat
administr
maxim
toler
dosag
ambisom
mgkgday
may
provid
effect
therapeut
result
addit
although
postantifung
effect
candida
speci
disregard
may
attribut
amphotericin
b
flucytosin
aim
antimicrobi
therapi
increas
csf
drug
concentr
mic
greater
possibl
complet
erad
infect
exist
direct
relationship
peak
concentr
amphotericin
b
plasma
auc
cerebr
tissu
concentr
correl
directli
greater
antifung
efficaci
thu
azoleresist
candida
shunt
infect
occur
high
dose
ambisom
mgkgday
may
reason
option
particular
vitamin
c
increas
resist
chick
embryo
tracheal
organ
cultur
infect
caus
avian
coronaviru
studi
anim
found
vitamin
c
modifi
suscept
variou
bacteri
viral
infect
exampl
protect
broiler
chick
avian
coronaviru
placebocontrol
trial
shown
quit
consist
durat
sever
common
cold
episod
reduc
vitamin
c
group
indic
viral
respiratori
infect
human
affect
vitamin
c
level
also
evid
indic
vitamin
c
may
affect
pneumonia
particular
three
control
trial
human
subject
report
significantli
lower
incid
pneumonia
vitamin
csupplement
group
suggest
vitamin
c
may
affect
suscept
lower
respiratori
tract
infect
certain
condit
possibl
vitamin
c
affect
sever
viral
respiratori
tract
infect
would
seem
warrant
studi
especi
light
recent
sar
epidem
